Thermo Fisher ScientificTMOEarnings & Financial Report
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006.
TMO Q3 2025 Key Financial Metrics
売上高
$11.1B
粗利益
N/A
営業利益
$1.9B
純利益
$1.6B
粗利益率
N/A
営業利益率
17.5%
純利益率
14.5%
前年比成長
4.9%
EPS
$4.27
資金フロー
Thermo Fisher Scientific Q3 2025 Financial Summary
Thermo Fisher Scientific reported revenue of $11.1B for Q3 2025, with a net profit of $1.6B (14.5% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $11.1B |
|---|---|
| Net Profit | $1.6B |
| Gross Margin | N/A |
| Operating Margin | 17.5% |
| Report Period | Q3 2025 |
Thermo Fisher Scientific Annual Revenue by Year
Thermo Fisher Scientific annual revenue history includes year-by-year totals (for example, 2024 revenue was $42.9B).
| Year | Annual Revenue |
|---|---|
| 2024 | $42.9B |
| 2023 | $43.0B |
| 2022 | $45.3B |
損益計算書
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $10.89B | $10.35B | $10.54B | $10.60B | $11.39B | $10.36B | $10.86B | $11.12B |
| 前年比成長 | -4.9% | N/A | -1.6% | -0.8% | N/A | 0.2% | 3.0% | 4.9% |
貸借対照表
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $98.73B | $97.09B | $98.50B | $100.36B | $97.32B | $99.04B | $101.23B | $103.02B |
| 総負債 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 株主資本 | $46.73B | $45.52B | $47.43B | $48.99B | $49.58B | $49.39B | $50.51B | $51.02B |
キャッシュフロー
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $3.72B | $1.25B | $1.96B | $2.17B | $3.29B | $723.0M | $1.40B | $2.24B |
Other Health Care Companies
A
Agilent Technologies
売上高
$1.9B
純利益
$434.0M
TECH
Bio-Techne
売上高
$295.9M
純利益
$38.0M
CRL
Charles River Laboratories
売上高
$994.2M
純利益
$-276.6M
DHR
Danaher Corporation
売上高
$6.1B
純利益
$908.0M
IQV
IQVIA
売上高
$4.4B
純利益
$514.0M
MTD
Mettler Toledo
売上高
$1.1B
純利益
$285.8M
ABT
Abbott Laboratories
売上高
$11.4B
純利益
$1.6B
ABBV
AbbVie
売上高
$15.8B
純利益
$186.0M
ALGN
Align Technology
売上高
$995.7M
純利益
$56.8M
AMGN
Amgen
売上高
$9.9B
純利益
$1.3B